Cases & Deals

AbbVie invests in Avaxia Biologics

Clients AbbVie Inc.

Jones Day advised AbbVie Inc., a leading pharmaceutical research and development company, in connection with its purchase of Series B Preferred Stock in a private placement by Avaxia Biologics, Inc., a clinical-stage biotechnology company focused on the development of orally-delivered antibody therapeutics.